Glaxo ends pact

Glaxo ends pact

GLAXO WELLCOME and Warner-Lambert, the US drug group, yesterday terminated a joint venture for the over-the-counter marketing of the UK company's anti-ulcer drug, Zantac. Under the terms of the new agreement, Glaxo will market Zantac in every country outside the US and Canada, where Warner- Lambert will retain the existing marketing rights.